OA
TMO icon

Oxbow Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Oxbow Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-768
Closed -$446K – 245
2024
Q1 		$446K Sell
768
-15
-2% -$8.42K 0.06% 134
2023
Q4 		$416K Hold
783
– – 0.06% 134
2023
Q3 		$396K Hold
783
– – 0.06% 133
2023
Q2 		$409K Hold
783
– – 0.06% 141
2023
Q1 		$451K Hold
783
– – 0.08% 132
2022
Q4 		$431K Buy
+783
New +$415K 0.08% 141

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Oxbow Advisors's TMO Position: Q2 2024 in Review

Oxbow Advisors sold out of Thermo Fisher Scientific (TMO) in Q2 2024, closing a stake of 768 shares — an estimated $446K sold.

Oxbow Advisors first reported a position in TMO in Q4 2022 and held it in 6 quarters. The position peaked at $451K in Q1 2023. 2,542 funds tracked by Wall St. Rank hold TMO as of Q2 2024.

  • Oxbow Advisors reported no remaining Thermo Fisher Scientific position as of Q2 2024 after selling out during the quarter.
  • Oxbow Advisors sold 768 Thermo Fisher Scientific shares in Q2 2024, an estimated $446K.
  • Oxbow Advisors first reported a position in Thermo Fisher Scientific in Q4 2022 and held it in 6 quarters.
  • Oxbow Advisors's Thermo Fisher Scientific position peaked at $451K in Q1 2023.
  • 2,542 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2024.

Based on Oxbow Advisors's 13F filing for Q2 2024, filed 6 Aug 2024.